Lactic Acidosis / Hyperlactatemia

Lactic Acidosis
Hyperlactatemia
  Symptoms and Laboratory Findings   Defining the Syndrome
  Defining the Syndrome  Prevalence
  NRTIs and Pathogenesis  Incidence in Patients Receiving NRTIs
  In Vitro Effects of NRTIs  Incidence Rate for Specific NRTIs
  Frequency  Relative Risk Compared with ZDV/3TC-
   Containing Regimens
  Clinical Features
  Outcomes and Risk Factors  Switching d4T for ZDV or ABC in Patients
   with Fat Wasting – Effect on Lactate
  Treatment
  Summary and Conclusions  Summary and Conclusions

Articles on Lactic Acidosis / Hyperlactatemia

Lactic Acidosis in HAART-treated Women in Botswana, Africa - 10/16/07

Role of Traditional Risk Factors vs HAART in the Development of Metabolic Syndrome   - 2/09/07


Hyperlactatemia in HIV Positive Patients: Is There a Need for Routine Lactate Monitoring? - 9/02/05

Possible Explanation for CD4+ Cell Decline in HIV Patients with Complete Virus Suppression Taking Tenofovir and Didanosine
- 4/08/05


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 







 

HIV AND AIDS
| HEPATITIS B | HEPATITIS C | HIV / HBV CO-INFECTION | HIV / HCV CO-INFECTION | HEALTH AND TECHNOLOGY | TESTS | INTERNET CONFERENCE REPORTS | TELECONFERENCES | LINKS | ABOUT US | CONTACT US